Patient‐Personalized Membrane‐Coated Magnetic Nanovectors: Probing the Biomimetic Interface for Targeted Tumor Theranostics
Achieving selective tumor targeting remains a major challenge in heterogeneous tumors like glioblastoma (GBM), the most aggressive brain cancer. To address this, cell‐derived magnetic nanovectors, hybrid lipid nanoparticles integrating iron oxide nanoparticles (IONPs) cloaked with plasma membranes from patient‐derived...